Literature DB >> 33550333

[Expression of cartilage oligomeric matrix protein in the synovial chondromatosis of the temporomandibular joint].

W H Han1, H Y Luo2, C B Guo1, Q Ning1, J H Meng1.   

Abstract

OBJECTIVE: To detect the expression of cartilage oligomeric matrix protein (COMP) in the synovial chondromatosis of the temporomandibular joint (TMJSC), and to discuss the possible interactions between COMP, transforming growth factor (TGF)-β3, TGF-β1 and bone morphogenetic protein-2 (BMP-2) in the development of this neoplastic disease.
METHODS: Patients in Peking University School and Hospital of Stomatology from January 2011 to February 2020 were selected, who had complete medical records, TMJSC was verified histologically after operation. The expressions of COMP, TGF-β3, TGF-β1 and BMP-2 in the TMJSC of the temporomandibular joint were detected by immunohistochemistry and quantitative real-time PCR (RT-PCR) at the protein level and mRNA level respectively, compared with the normal synovial tissue of temporomandibular joint. The histological morphology, protein expression and distribution of TMJSC tissues were observed microscopically, and the positive staining proteins were counted and scored. SPSS 22.0 statistical software was used to analyze the expression differences between the related proteins in TMJSC tissue and the normal synovial tissue of temporomandibular joint and to compare their differences. P < 0.05 indicated that the difference was statistically significant.
RESULTS: Immunohistochemical results showed that the positive expression of COMP in TMJSC tissues was mostly found in synovial tissues and chondrocytes adjacent to synovial tissues, and the difference was statistically significant, compared with the normal temporomandibular joint synovial tissues. The positive expression of COMP was significantly different between recurrent TMJSC and non-recurrent ones. The positive expressions of TGF-β3, TGF-β1 and BMP-2 were higher than the normal synovial tissue, and were also mostly found in the synovial cells and adjacent chondrocytes, which was further confirmed by Western blot. According to the RT-PCR results, the expressions of COMP, TGF-β3, TGF-β1 and BMP-2 in TMJSC were higher than those in the normal synovial tissue.
CONCLUSION: The expression of COMP in TMJSC of temporomandibular joint increased significantly, compared with the normal synovial tissue. There may be interactions between COMP and cytokines related to the proliferation and differentiation, like TGF-β3, TGF-β1 and BMP-2, which may play a potential role in the pathogenesis of TMJSC.

Entities:  

Keywords:  Bone morphogenetic protein-2; Cartilage oligomeric matrix protein; Synovial chondromatosis; Temporomandibular joint; Transforming growth factor

Mesh:

Substances:

Year:  2020        PMID: 33550333      PMCID: PMC7867961     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  24 in total

1.  Synovial chondromatosis of the temporomandibular joint with immunohistochemical findings: report of a case.

Authors:  S Fujita; T Iizuka; Y Tuboi; Y Hyou
Journal:  J Oral Maxillofac Surg       Date:  1991-08       Impact factor: 1.895

2.  Synovial chondromatosis of the temporomandibular joint: report and analysis of eleven cases.

Authors:  Leon Ardekian; William Faquin; Maria J Troulis; Leonard B Kaban; Meredith August
Journal:  J Oral Maxillofac Surg       Date:  2005-07       Impact factor: 1.895

3.  Chondroprogenitor cells of synovial tissue.

Authors:  K Nishimura; L A Solchaga; A I Caplan; J U Yoo; V M Goldberg; B Johnstone
Journal:  Arthritis Rheum       Date:  1999-12

4.  Synovial chondromatosis associated with experimental osteoarthritis in adult monkeys.

Authors:  E S Helmy; R A Bays; M M Sharawy
Journal:  J Oral Maxillofac Surg       Date:  1989-08       Impact factor: 1.895

5.  Cartilage oligomeric matrix protein improves in vivo cartilage regeneration and compression modulus by enhancing matrix assembly and synthesis.

Authors:  Chongyang Wang; Guangwang Liu; Wen Zhang; Wei Wang; Chao Ma; Shen Liu; Cunyi Fan; Xudong Liu
Journal:  Colloids Surf B Biointerfaces       Date:  2017-08-16       Impact factor: 5.268

6.  Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes.

Authors:  F Zaucke; R Dinser; P Maurer; M Paulsson
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene.

Authors:  H Li; D R Haudenschild; K L Posey; J T Hecht; P E Di Cesare; J H N Yik
Journal:  Osteoarthritis Cartilage       Date:  2011-07-29       Impact factor: 6.576

Review 8.  Synovial chondromatosis: a case study and brief review.

Authors:  M J Coles; H H Tara
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1997-01

9.  Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures.

Authors:  K Blumbach; Y M Bastiaansen-Jenniskens; J DeGroot; M Paulsson; G J V M van Osch; F Zaucke
Journal:  Arthritis Rheum       Date:  2009-12

10.  Tenascin: cDNA cloning and induction by TGF-beta.

Authors:  C A Pearson; D Pearson; S Shibahara; J Hofsteenge; R Chiquet-Ehrismann
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.